← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2016Last known activity
Sep 1, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (22 distinct, 11 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Recent trials (11)
- NCT06902740CollaboratorPhase 4Sep 1, 2025
- NCT07019012CollaboratorPhase 4Jul 30, 2025
- NCT06696820CollaboratorPhase 4Dec 1, 2024
- NCT06470256CollaboratorPhase 1Jun 1, 2024
- NCT06265051CollaboratorPhase 2/Phase 3Apr 9, 2024
- NCT06345365CollaboratorPhase 3Jan 18, 2024
- NCT06009991CollaboratorN/AJul 17, 2023
- NCT05961202CollaboratorPhase 2/Phase 3Jan 1, 2022
- NCT04519905CollaboratorN/AJan 6, 2020
- NCT03153293CollaboratorPhase 2/Phase 3Sep 1, 2017
- NCT02857153CollaboratorN/AJul 1, 2016
Details
- Last known activity
- Sep 1, 2025